Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

South Korea · Delayed Price · Currency is KRW

5,280.00

-80.00 (-1.49%)

Last updated: Feb 26, 2026, 2:10 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical	162.68B	129.49B	196.93B	182.49B	169.66B
Pharmaceutical Growth	25.64%	-34.25%	7.91%	7.56%	-
Consolidation Adjustments	-2.60B	-3.56B	-6.02B	-	-
Total	160.09B	125.93B	190.91B	182.49B	169.66B
Total Growth	27.13%	-34.04%	4.61%	7.56%	0.87%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	160.05B	125.78B	190.71B	182.43B	169.48B
South Korea Growth	27.25%	-34.05%	4.54%	7.64%	0.81%
Overseas	37.76M	149.84M	202.44M	61.00M	183.15M
Overseas Growth	-74.80%	-25.99%	231.89%	-66.70%	117.74%
Total	160.09B	125.93B	190.91B	182.49B	169.66B
Total Growth	27.13%	-34.04%	4.61%	7.56%	0.87%

Source: S&P Global Market Intelligence.